IL-6, A1 and A2aR: a crosstalk that modulates BDNF and induces neuroprotection

Area of Science:

• Neuroscience
• Ophthalmology
• Cell Biology

Background:

• Retinal ganglion cell (RGC) death is implicated in diseases like glaucoma and diabetes.
• Identifying neuroprotective factors for RGCs after axotomy is crucial for treating vision loss.
• Interleukin-6 (IL-6) has demonstrated potential in enhancing RGC survival and regeneration.

Purpose of the Study:

• To elucidate the mechanisms underlying the neuroprotective effects of IL-6 on RGCs.
• To investigate the role of adenosine receptors and BDNF in IL-6-mediated RGC survival.
• To explore the intricate cross-talk between IL-6, BDNF, and adenosine receptors in RGC neuroprotection.

Main Methods:

• In vitro studies using mixed cultures of RGCs.
• In vivo experiments to assess RGC survival and regeneration.
• Pharmacological manipulation of adenosine receptors (A1 and A2a) and assessment of BDNF levels.

Main Results:

• IL-6 significantly increases RGC survival and regeneration.
• The trophic effect of IL-6 is dependent on adenosine A2a receptor (A2aR) activation.
• Extracellular brain-derived neurotrophic factor (BDNF) is essential for IL-6's neuroprotective action.
• A complex cross-talk network involving IL-6, BDNF, A1, and A2a receptors was identified, leading to RGC neuroprotection.

Conclusions:

• IL-6 exerts neuroprotection on RGCs through a mechanism involving A2aR activation and BDNF.
• The interplay between IL-6, BDNF, and adenosine receptors is critical for maintaining RGC health.
• These findings offer potential therapeutic targets for neurodegenerative diseases affecting the retina.